Former Cardinal Unit Has Healthy Outlook
Investor's Business Daily - Fri Nov 27, 5:07 pm ETLike most executives at companies that deal in health care, Dave Schlotterbeck will keep a close watch on how U.S. lawmakers proceed with health care reform.
Food and Drug Administration
4813 Stories, most recent news story added Fri Nov 27, 4:56 pm ET
News Stories
-
Novartis says FDA approves Agriflu seasonal shot
INO News - Fri Nov 27, 4:56 pm ET(AP:NEW YORK) The Food and Drug Administration said Friday it cleared Novartis' seasonal flu vaccine Agriflu for sale. Agriflu is given as a single shot, and is approved for seasonal flu subtypes A and B in people age 18 and older.
-
Surgery for Mental Ills Offers Both Hope and Risk
International Herald Tribune - Thu Nov 26, 10:35 pm ETHundreds have undergone brain surgery for problems like depression, anxiety, even obesity.
-
What out for cleaners that look a lot like mouthwash
St. Petersburg Times - Fri Nov 27, 11:39 am ETHere's a strange twist: you can find a child safety cap on a bottle of Listerine mouthwash, but not on Lysol, Pine Sol or Mr. Clean.Go figure.
-
Dallas-area clinics ignore proposed rules, still push for mammograms
Dallas Morning News - Fri Nov 27, 12:13 am ETDozens of Dallas-area clinics that offer mammograms are largely ignoring new guidelines that could drastically reduce the amount of breast-cancer screening in the U.S.
-
Surgery for Mental Ills Offers Hope and Risk
The Tuscaloosa News - Fri Nov 27, 5:43 am ETBENEDICT CAREY Hundreds have undergone brain surgery for problems like depression, anxiety, even obesity.
-
Community blood drives in December to benefit cancer patients
The Advertiser-News - Fri Nov 27, 2:39 am ETNew Jersey Blood Services is conducting blood drives in the area which are open to the public. Here is a list of the following drives that are upcoming:
-
Lilly, Bristol’s Erbitux Reduced Symptoms of Stomach Disorder
Bloomberg - Wed Nov 25, 2:22 pm ETNov. 25 (Bloomberg) -- Bristol-Myers Squibb Co. and Eli Lilly & Co .’s cancer treatment Erbitux helped reduce pain and nausea in patients with a rare, precancerous stomach disorder, in a small trial.
-
'Remarkable faith'
Daily Local News - Thu Nov 26, 6:18 am ETNEWLIN — Gail McWilliams, who has an aggressive form of brain cancer, is looking forward to spending time with her family this Thanksgiving Day.
-
Human Genome Sciences seeks approval for Zalbin
INO News - Wed Nov 25, 11:56 am ET(AP:NEW YORK) Human Genome Sciences Inc. said Wednesday it has filed for marketing approval of its hepatitis C drug Zalbin. The Rockville, Md., company did not say when it expected a response to its biologics license application, which was submitted to the Food and Drug Administration.
-
Schumer: Crack down on phony flu products
The Goshen Chronicle - Thu Nov 26, 2:33 am ETALBANY U.S. Sen. Charles Schumer is calling for a crackdown on what he says are phony pills, gloves, inhalers, masks, shampoos and even air fresheners sold on the Internet as remedies for swine flu.
-
Canada pulls vaccine doses
USA Today - Tue Nov 24, 9:04 pm ETThe drug company has told doctors to stop using one lot of its H1N1 vaccine until an inquiry into severe allergic reactions is done.
-
FDA grants full approval to J&J's HIV drug
Seattle Times - Wed Nov 25, 4:45 pm ETA division of Johnson & Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
-
New ingredient boosts vitamin C bioavailability: Study
Nutraingredients.com - Wed Nov 25, 12:13 pm ETFast-C, developed by Scientific Food Solutions and distributed by ET Horn in partnership as Alkemy Partners, achieves faster entry of vitamin C into the blood while urinary excretion was slightly less, suggesting excellent retention by tissues, according to the study’s authors.
-
FDA grants full approval to J&J's HIV drug
The Daily Reflector - Wed Nov 25, 4:22 pm ETBRIDGEWATER, N.J. — A division of Johnson&Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
-
FDA grants full approval to J&J's HIV drug
FOX 12 Idaho - Wed Nov 25, 4:14 pm ETA division of Johnson&Johnson said Wednesday that federal regulators granted full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
FDA: Recalls
-
Stryker Corporation’s Instruments Division Issues Worldwide Class 1 Recall of 23 Operating Room System II Surgical Navigation Systems; Catalog numbers 7700-100-000 and 7700-101-201
Wed Nov 25, 3:10 pm EST -
Vita Food Products, Inc. Issues an Alert Announcing Undeclared Wheat in ELF Branded Herring in Sour Cream
Wed Nov 25, 12:44 pm EST -
Timco Worldwide Inc. issuance of a voluntary recall of Large Seedless Watermelons because of possible health risk
Tue Nov 24, 9:11 am EST -
Unilever Issues Nationwide Allergy Alert on Undeclared Sulfites in Certain Shedd’s Country Crock® Chilled Side-Dish Products
Mon Nov 23, 10:26 am EST -
Five Crowns Marketing Voluntarily Recalling Cantaloupes Packed under the Majesty Label Because of a Potential Health Risk Due to Possible Contamination of Salmonella
Fri Nov 20, 6:14 pm EST
Most Blogged About
-
Brain Power: Surgery for Mental Ills Offers Both Hope and Risk
New York Times - Thu Nov 26, 10:27 pm EST
